Anpartsselskabet af 21.08.2026

CVR 39119374 · Private limited company (ApS) · In voluntary liquidation

Anpartsselskabet af 21.08.2026 is a Private limited company (ApS), founded on , based in København V. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is no longer active (status: in voluntary liquidation). 8 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 807k and a net result of DKK 48k.

Company details

CVR number
39119374
Status
In voluntary liquidation
Company type
Private limited company (ApS)
Founded
Address
c/o Gorrissen Federspiel, Axeltorv 2
1609 København V
Municipality
København
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 52k
Employees
7 (2018)
Audit opted out
Yes

Warning signs

Annual reports filed late0 of 8
Missing annual reportNo
Negative equityNo
Equity ratio96.9%
Current ratio3,204%
Moves (last 2 years)1
CEO changes in total4
CEO's previous bankruptcies0
Other companies at the address308
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -1,000DKK -38k
Net profitDKK 48kDKK 6.2m
EquityDKK 807kDKK 6.8m
Total assetsDKK 833kDKK 8.5m
CashDKK 662k–
Short-term debtDKK 26k–
Tax owedDKK 13k–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: No audit assistance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025162
1 Jan 2024 – 31 Dec 2024169
1 Jan 2023 – 31 Dec 2023180
1 Jan 2022 – 31 Dec 2022165
1 Jan 2021 – 31 Dec 2021164
1 Jan 2020 – 31 Dec 2020165
1 Jan 2019 – 31 Dec 2019153
28 Nov 2017 – 31 Dec 2018148

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOJakob Bondo Hansen
CEOTrine Haastrup
BoardCasper Tind Hansen
BoardKlaus Christian Schollmeier
BoardPeter Bøggild
BoardKristine Aachmann Bethe
Owner (100%)NOVO NORDISK A/SCurrent
Owner (15%)CTH Holding Invest ApS
Owner (25%)Bondo Hansen Holding ApS
Owner (25%)Gerhart-Hines Holding ApS
Owner (25%)Receptor Holding ApS
Owner (90%)Embark Holdings ApS
AuditorEY Godkendt Revisionspartnerselskab
FounderCTH Holding Invest ApSCurrent

The CEOs' other companies

Jakob Bondo Hansen – 1 other companies

Trine Haastrup – 3 other companies

Address history (2 moves)

c/o Gorrissen Federspiel, Axeltorv 2, 1609 København V
Novo Alle 1, 2880 Bagsværd
c/o COBIS, Ole Maaløes Vej 3, 2200 København N

Former names

Anpartsselskabet af 21.08.2026 – now
Novo Nordisk Research Center Gladsaxe ApS –
Embark Biotech ApS –
Embark Biotech IvS –

Employees per year

Number of employees at Anpartsselskabet af 21.08.2026 per year472018: 72018

Other companies at the same address

Similar companies in København

Questions and answers about Anpartsselskabet af 21.08.2026

Has Anpartsselskabet af 21.08.2026 gone bankrupt?

No, Anpartsselskabet af 21.08.2026 is not registered as bankrupt in the CVR register. Its status is: in voluntary liquidation.

When was Anpartsselskabet af 21.08.2026 founded?

Anpartsselskabet af 21.08.2026 was founded on 28 November 2017.

What is the equity of Anpartsselskabet af 21.08.2026?

Equity was DKK 807k according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.